Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paricalcitol for Anemia in CKD
NCT01768351Phase 4Completed
- Sponsor
- University of Naples Federico II
- Start
- Oct 2010
- Primary completion
- Mar 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of paricalcitol in anemia (2 arms), sponsored by University of Naples Federico II. Primary endpoint: Modification in hemoglobin levels at 6 months. Started Oct 2010; status: completed.
02
Drugs
paricalcitol
03
Conditions
anemia
Beyond the preview
Go deeper on NCT01768351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01768351.